Exercise capacity and cardiovascular/metabolic characteristics of overweight and obese individuals with type 2 diabetes - The look AHEAD clinical trial

被引:72
|
作者
Ribisl, Paul M.
Lang, Wei
Jaramillo, Sarah A.
Jakicic, John M.
Stewart, Kerry J.
Bahnson, Judy
Bright, Renee
Curtis, Jeff F.
Crow, Richard S.
Soberman, Judith E.
机构
[1] Wake Forest Univ, Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA
[2] Univ Pittsburgh, Dept Hlth & Phys Act, Pittsburgh, PA USA
[3] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA
[4] Brown Univ, Brown Med Sch, Miriam Hosp, Providence, RI 02912 USA
[5] NIDDK, Diabet Epidemiol & Clin Res Sect, Phoenix, AZ USA
[6] Univ Minnesota, Dept Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Cardiol, Memphis, TN 38163 USA
关键词
D O I
10.2337/dc06-2487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined associations of cardiovascular, metabolic, and body composition measures with exercise capacity using baseline data from 5,145 over-weight and/or obese (BMI >= 25.0 kg/m(2)) men and women with type 2 diabetes who were randomized participants for the Look AHEAD (Action for Health in Diabetes) clinical trial. RESEARCH DESIGN AND METHODS - Peak exercise capacity expressed as METs and estimated from treadmill speed and grade was measured during a graded exercise test 2 designed to elicit a maximal effort. Other measures included waist circumference, BMI, type diabetes duration, types of medication used, A1C, history of cardiovascular disease, metabolic syndrome, P-blocker use, and race/ethnicity. RESULTS - Peak exercise capacity was higher for men (8.0 +/- 2.1 METs) than for women (6.7 +/- 1.7 METs) (P < 0.001). Exercise capacity also decreased across each decade of age (P < 0.001) and with increasing BMI and waist circumference levels in both sexes. Older age, increased waist circumference and BMI, a longer duration of diabetes, increased A1C, a history of cardiovascular disease, having metabolic syndrome, P-blocker use, and being African American compared with being Caucasian were associated with a lower peak exercise capacity for both sexes. Hypertension and use of diabetes medications were associated with lower peak exercise capacity in women. CONCLUSIONS - Individuals with diabetes who are overweight or obese have impaired exercise capacity, which is primarily related to age, female sex, and race, as well as poor metabolic control, BMI, and central obesity.
引用
收藏
页码:2679 / 2684
页数:6
相关论文
共 50 条
  • [1] Metabolic syndrome is influenced by exercise capacity in overweight and obese individuals with type 2 diabetes
    Ribisl, P
    Bahnson, J
    Gaussoin, S
    Lang, W
    Jakicic, J
    Bright, R
    Crow, R
    Curtis, J
    Soberman, J
    Stewart, K
    OBESITY RESEARCH, 2005, 13 : A25 - A25
  • [2] Binge Eating and Weight Loss Outcomes in Overweight and Obese Individuals With Type 2 Diabetes Results From the Look AHEAD Trial
    Gorin, Amy A.
    Niemeier, Heather M.
    Hogan, Patricia
    Coday, Mace
    Davis, Cralen
    DiLillo, Vicki G.
    Gluck, Marci E.
    Wadden, Thomas A.
    West, Delia S.
    Williamson, Donald
    Yanovski, Susan Z.
    ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (12) : 1447 - 1455
  • [3] Binge eating and weight loss outcomes in overweight individuals with type 2 diabetes: Results from the look ahead clinical trial
    Gorin, A.
    Niemeier, H.
    Hogan, P.
    Coday, M.
    DiLillo, V.
    Gluck, M.
    Wadden, T.
    West, D.
    Williamson, D.
    Yanovski, S.
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S33 - S33
  • [4] One-Year Changes in Symptoms of Depression and Weight in Overweight/Obese Individuals With Type 2 Diabetes in the Look AHEAD Study
    Faulconbridge, Lucy F.
    Wadden, Thomas A.
    Rubin, Richard R.
    Wing, Rena R.
    Walkup, Michael P.
    Fabricatore, Anthony N.
    Coday, Mace
    Van Dorsten, Brent
    Mount, David L.
    Ewing, Linda J.
    OBESITY, 2012, 20 (04) : 783 - 793
  • [5] Exercise Capacity and Mortality in Hypertensive, Obese Individuals with Type 2 Diabetes Mellitus
    Charles, Faselis
    Raya, Kheirbek
    Helen, Sheriff
    Eric, Nylen
    Peter, Kokkinos John
    Bradley, Gelfand W.
    Andreas, Pittaras
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15
  • [6] Intensive Lifestyle Intervention Reduces Urinary Incontinence in Overweight/Obese Men with Type 2 Diabetes: Results from the Look AHEAD Trial
    Breyer, Benjamin N.
    Phelan, Suzanne
    Hogan, Patricia E.
    Rosen, Raymond C.
    Kitabchi, Abbas E.
    Wing, Rena R.
    Brown, Jeanette S.
    JOURNAL OF UROLOGY, 2014, 192 (01): : 144 - 149
  • [7] Prevalence and Predictors of Abnormal Cardiovascular Responses to Exercise Testing Among Individuals With Type 2 Diabetes The Look AHEAD (Action for Health in Diabetes) study
    Curtis, Jeffrey M.
    Horton, Edward S.
    Bahnson, Judy
    Gregg, Edward W.
    Jakicic, John M.
    Regensteiner, Judith G.
    Ribisl, Paul M.
    Soberman, Judith E.
    Stewart, Kerry J.
    Espeland, Mark A.
    DIABETES CARE, 2010, 33 (04) : 901 - 907
  • [8] Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial
    Kleinberger, Jeffrey W.
    Copeland, Kenneth C.
    Gandica, Rachelle G.
    Haymond, Morey W.
    Levitsky, Lynne L.
    Linder, Barbara
    Shuldiner, Alan R.
    Tollefsen, Sherida
    White, Neil H.
    Pollin, Toni I.
    GENETICS IN MEDICINE, 2018, 20 (06) : 583 - 590
  • [9] Physical Fitness and Diabetic Nephropathy in the Look AHEAD Clinical Trial in Type 2 Diabetes
    Hellgren, Margareta I.
    Curtis, Jeffrey M.
    Pomeroy, Jeremy
    Weil, Jennifer
    Nelson, Robert G.
    Jakicic, John M.
    Knowler, William C.
    DIABETES, 2015, 64 : A22 - A22
  • [10] Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes
    Brancati, F
    Charleston, J
    Cheskin, L
    Clark, J
    DiGregorio-Celnik, D
    Friedman-Donze, L
    Rubin, R
    Stewart, K
    Bray, GA
    DeLee, DG
    Boss, KR
    Greenway, FL
    Lovejoy, JC
    Ryan, DH
    Williamson, DA
    West, DS
    DiLillo, V
    Raczynski, JM
    Lewis, CE
    Oberman, A
    Thomas, S
    Nathan, DM
    Horton, ES
    Turgeon, H
    Jackson, SD
    Blackburn, GL
    Delahanty, L
    Steiner, B
    Cagliero, E
    Mantzoros, C
    Hill, JO
    Phillipp, J
    Hamman, RF
    Schwartz, R
    Regensteiner, J
    Van Dorsten, B
    McDermott, MT
    Dills, DG
    Foreyt, JP
    Reeves, RS
    Pownell, HJ
    Balasubramanyam, A
    Jones, PH
    Saad, MF
    Jinagouda, S
    Chiu, K
    Morales, L
    Ghazarian, S
    Navarrete, G
    Iqbal, N
    CONTROLLED CLINICAL TRIALS, 2003, 24 (05): : 610 - 628